应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
06185 康希诺生物
交易中 09-01 11:04:31
29.280
-0.220
-0.75%
最高
30.960
最低
28.900
成交量
432.49万
今开
29.960
昨收
29.500
日振幅
6.98%
总市值
72.33亿
流通市值
38.85亿
总股本
2.47亿
成交额
1.30亿
换手率
3.26%
流通股本
1.33亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
智通AH统计|8月31日
智通财经 · 08-31 16:15
智通AH统计|8月31日
异动解读|康希诺生物盘中下跌5.48%,前期多重利好驱动大涨后获利回吐压力持续释放
行情直击 · 08-31 09:45
异动解读|康希诺生物盘中下跌5.48%,前期多重利好驱动大涨后获利回吐压力持续释放
智通AH统计|8月28日
智通财经 · 08-28
智通AH统计|8月28日
异动解读|康希诺生物盘中下跌5.4%,中期业绩发布后短期获利回吐压力延续
行情直击 · 08-28
异动解读|康希诺生物盘中下跌5.4%,中期业绩发布后短期获利回吐压力延续
营收增长超40% 海外收入过亿 康希诺生物国际化从“布局”走向“兑现”
格隆汇 · 08-27
营收增长超40% 海外收入过亿 康希诺生物国际化从“布局”走向“兑现”
康希诺生物股份公司(06185)2026年上半年收入同比增43.81%
公告速递 · 08-27
康希诺生物股份公司(06185)2026年上半年收入同比增43.81%
康希诺生物(06185.HK)公布中期业绩 净亏损72.1万元 同比收窄94.65%
智通财经 · 08-27
康希诺生物(06185.HK)公布中期业绩 净亏损72.1万元 同比收窄94.65%
异动解读|康希诺生物盘中下跌5.04%,mRNA肿瘤疫苗合作消息刺激大涨后回调
行情直击 · 08-27
异动解读|康希诺生物盘中下跌5.04%,mRNA肿瘤疫苗合作消息刺激大涨后回调
【券商聚焦】国投证券:创新药有望开启新一轮高景气周期
金吾财讯 · 08-27
【券商聚焦】国投证券:创新药有望开启新一轮高景气周期
康希诺生物(06185)披露mRNA技术平台最新进展并签订肿瘤疫苗合作框架协议
公告速递 · 08-26
康希诺生物(06185)披露mRNA技术平台最新进展并签订肿瘤疫苗合作框架协议
A股收评:沪指涨0.59%,超2900股上涨!大金融、有色金属板块领涨
格隆汇 · 08-26
A股收评:沪指涨0.59%,超2900股上涨!大金融、有色金属板块领涨
港股速报 | 港股继续高开 马云出手 阿里巴巴涨超2%
每日经济新闻 · 08-26
港股速报 | 港股继续高开 马云出手 阿里巴巴涨超2%
港股生物医药股大涨,康希诺生物涨逾18%
新浪港股 · 08-26
港股生物医药股大涨,康希诺生物涨逾18%
港股异动 | 康希诺生物大升16%,与德普世生物达成mRNA个性化治疗型肿瘤疫苗战略合作
智通财经 · 08-26
港股异动 | 康希诺生物大升16%,与德普世生物达成mRNA个性化治疗型肿瘤疫苗战略合作
异动解读|康希诺生物盘中上涨14.34%,与德普世生物达成mRNA肿瘤疫苗战略合作
行情直击 · 08-26
异动解读|康希诺生物盘中上涨14.34%,与德普世生物达成mRNA肿瘤疫苗战略合作
康希诺生物与德普世生物达成mRNA治疗型肿瘤疫苗战略合作
格隆汇 · 08-25
康希诺生物与德普世生物达成mRNA治疗型肿瘤疫苗战略合作
康希诺生物(06185)将于9月3日举行线上半年报业绩说明会
公告速递 · 08-25
康希诺生物(06185)将于9月3日举行线上半年报业绩说明会
智通AH统计|8月25日
中金财经 · 08-25
智通AH统计|8月25日
异动解读|康希诺生物盘中下跌5.16%,mRNA癌症疫苗消息刺激暴涨后持续回调
行情直击 · 08-24
异动解读|康希诺生物盘中下跌5.16%,mRNA癌症疫苗消息刺激暴涨后持续回调
【券商聚焦】交银国际:中国内地mRNA疫苗产业整体低估严重
金吾财讯 · 08-24
【券商聚焦】交银国际:中国内地mRNA疫苗产业整体低估严重
加载更多
公司概况
公司名称:
康希诺生物
所属市场:
SEHK
上市日期:
--
主营业务:
康希诺生物股份公司是一家处于临床阶段的中国疫苗公司。该公司的产品包括埃博拉病毒疫苗Ad5-EBOV、脑膜炎球菌疫苗MCV2和MCV4、肺炎球菌疫苗PBPV和重组新型冠状病毒疫苗等。其产品主要应用于脑膜炎、百白破和肺炎领域。
发行价格:
--
{"stockData":{"symbol":"06185","market":"HK","secType":"STK","nameCN":"康希诺生物","latestPrice":29.28,"timestamp":1788231862602,"preClose":29.5,"halted":0,"volume":4324880,"delay":0,"changeRate":-0.007457627118644029,"floatShares":132670900,"shares":247043801,"eps":0.11,"marketStatus":"交易中","change":-0.22,"latestTime":"09-01 11:04:31","open":29.96,"high":30.96,"low":28.9,"amount":129534028,"amplitude":0.069831,"askPrice":29.28,"askSize":3800,"bidPrice":29.26,"bidSize":16600,"shortable":3,"etf":0,"ttmEps":0.189,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1788235200000},"marketStatusCode":2,"adr":0,"listingDate":1553702400000,"exchange":"SEHK","adjPreClose":29.5,"openAndCloseTimeList":[[1788226200000,1788235200000],[1788238800000,1788249600000]],"volumeRatio":0.898033,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688185","market":"SH","secType":"STK","nameCN":"康希诺","latestPrice":74.45,"timestamp":1788231867000,"preClose":75.41,"halted":0,"volume":6460300,"delay":0,"premium":"-66.28"}},"requestUrl":"/m/hq/s/06185","defaultTab":"news","newsList":[{"id":"2663073923","title":"智通AH统计|8月31日","url":"https://stock-news.laohu8.com/highlight/detail?id=2663073923","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663073923?lang=zh_cn&edition=full","pubTime":"2026-08-31 16:15","pubTimestamp":1788164105,"startTime":"0","endTime":"0","summary":"东北电气0.2422.251015.70%2.16%浙江世宝3.96016.58401.52%51.14%弘业期货2.2407.91322.77%14.23%中石化油服0.6602.29315.15%6.17%复旦张江2.5208.09284.52%6.86%晨鸣纸业0.6101.91275.41%18.37%凯盛新能2.2957.18274.73%24.65%安德利果汁22.20067.75265.54%-13.04%南京熊猫电子股份3.3159.73251.43%9.64%京城机电股份2.8508.29248.42%16.04%. 康希诺生物29.50085.36246.58%74.87%浙江世宝3.96016.58401.52%51.14%山东墨龙4.7008.45115.32%30.05%凯盛新能2.2957.18274.73%24.65%晨鸣纸业0.6101.91275.41%18.37%上海电气2.9106.58170.79%17.02%京城机电股份2.8508.29248.42%16.04%沃尔核材10.07017.12103.67%14.52%中国国航3.7705.9488.59%14.33%丽珠医药19.88026.4759.51%14.26%. 备注:以上数据由智通机器人根据港交所数据,经过人工智能运算后自动生成,并不保证数据100%准确;偏离值为当前溢价率与该股过去30天平均溢价率的差值。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1489382.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00568","00187","02827","06185","00317","03986","06690","02475","02727","83130","00991","00042","03328","83188","02846","03143","06869","03200","02338","01877","01108","03130","01033","LU0348816934.USD","03308","02218","03188","LU0327786744.USD","03750","399300","03968","03268","02691","EWH","07233","00981","159982","01513","01057","01349","00753","02359","03296","09981","01812","00300","03678","82846","00553"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174279498","title":"异动解读|康希诺生物盘中下跌5.48%,前期多重利好驱动大涨后获利回吐压力持续释放","url":"https://stock-news.laohu8.com/highlight/detail?id=1174279498","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1174279498?lang=zh_cn&edition=full","pubTime":"2026-08-31 09:45","pubTimestamp":1788140739,"startTime":"0","endTime":"0","summary":"8月31日,康希诺生物盘中下跌5.48%,报29.78港元,成交额5268.4万港元。8月27日公司披露中期业绩,上半年营收5.50亿元,同比增长43.81%;净亏损72.08万元,较上年同期大幅收窄94.65%,基本面持续改善。然而业绩发布前股价已充分反映利好预期,8月27日以来连续多个交易日回调,获利盘兑现压力持续释放,今日延续回吐走势。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"康希诺生物下跌,获利回吐压力持续","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662057084","title":"智通AH统计|8月28日","url":"https://stock-news.laohu8.com/highlight/detail?id=2662057084","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662057084?lang=zh_cn&edition=full","pubTime":"2026-08-28 16:15","pubTimestamp":1787904905,"startTime":"0","endTime":"0","summary":"东北电气0.2272.251089.43%80.24%浙江世宝3.97016.63401.76%52.78%弘业期货2.2808.05322.81%14.59%中石化油服0.6702.32314.93%6.56%复旦张江2.5358.28291.32%13.28%晨鸣纸业0.6151.93275.61%18.32%凯盛新能2.3157.18271.49%22.29%南京熊猫电子股份3.3109.66249.55%8.35%龙源电力5.44015.67245.04%0.09%京城机电股份2.9408.4242.18%10.23%. 兆易创新486.000405.74--%0.24%宁德时代616.500368.5-28.40%-2.18%药明康德197.100157.72-4.15%0.04%招商银行49.02039.39-3.75%0.58%中际旭创1040.000858.35-1.14%-2.86%潍柴动力32.76027.641.07%-1.84%美的集团98.75085.774.04%-1.42%立讯精密63.55056.726.91%-9.87%紫金矿业38.28034.658.41%-6.09%交通银行7.5107.113.18%-1.17%. 备注:以上数据由智通机器人根据港交所数据,经过人工智能运算后自动生成,并不保证数据100%准确;偏离值为当前溢价率与该股过去30天平均溢价率的差值。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1487873.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00568","01057","01812","03143","03986","03296","LU0359201885.HKD","03308","07233","06185","83188","01033","03678","00300","EWH","00981","00317","00638","01108","02475","00042","03750","03968","00553","02727","02338","03130","BK1594","159982","01989","02359","03188","00916","06869","02691","83130","06821","00187","00991","399300","02827","03200","82846","02846","02068","03908","03328","02899","01349"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147675691","title":"异动解读|康希诺生物盘中下跌5.4%,中期业绩发布后短期获利回吐压力延续","url":"https://stock-news.laohu8.com/highlight/detail?id=1147675691","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1147675691?lang=zh_cn&edition=full","pubTime":"2026-08-28 09:43","pubTimestamp":1787881397,"startTime":"0","endTime":"0","summary":"8月28日,康希诺生物盘中下跌5.4%,报33.3港元,成交额7712.74万港元。业绩表现积极,但此前受Moderna mRNA癌症疫苗三期临床成功及公司与德普世生物签署肿瘤疫苗合作协议等多重利好驱动,公司A股三日累涨逾30%、H股单日大涨逾16%,短期累计涨幅较大,获利盘兑现压力持续释放,8月27日已回调逾5%,今日延续回吐走势。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"康希诺生物盘中下跌,中期业绩后获利回吐延续","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662883710","title":"营收增长超40% 海外收入过亿 康希诺生物国际化从“布局”走向“兑现”","url":"https://stock-news.laohu8.com/highlight/detail?id=2662883710","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662883710?lang=zh_cn&edition=full","pubTime":"2026-08-27 21:13","pubTimestamp":1787836409,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK1161","BK1515","BK1191","06185","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178929196","title":"康希诺生物股份公司(06185)2026年上半年收入同比增43.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=1178929196","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1178929196?lang=zh_cn&edition=full","pubTime":"2026-08-27 19:27","pubTimestamp":1787830049,"startTime":"0","endTime":"0","summary":"2026年8月28日,康希诺生物股份公司披露2026年半年度报告。期内,公司实现营业收入5.50亿元,同比增长43.81%;利润总额603.79万元,上年同期为亏损1,930.34万元;归属于上市公司股东的净亏损72.08万元,较上年同期亏损1,348.54万元大幅收窄。报告期内,公司研发投入1.66亿元,研发投入占营业收入的比例为30.16%。截至2026年6月30日,公司总资产68.25亿元,较上年度末下降4.91%;归属于上市公司股东的净资产49.78亿元,同比增长0.49%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662701608","title":"康希诺生物(06185.HK)公布中期业绩 净亏损72.1万元 同比收窄94.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662701608","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662701608?lang=zh_cn&edition=full","pubTime":"2026-08-27 19:22","pubTimestamp":1787829727,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1574","06185","BK1161","BK1515","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135602422","title":"异动解读|康希诺生物盘中下跌5.04%,mRNA肿瘤疫苗合作消息刺激大涨后回调","url":"https://stock-news.laohu8.com/highlight/detail?id=1135602422","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1135602422?lang=zh_cn&edition=full","pubTime":"2026-08-27 09:39","pubTimestamp":1787794761,"startTime":"0","endTime":"0","summary":"8月27日,康希诺生物盘中下跌5.04%,报33.88港元,成交额8933.85万港元。消息面上,公司此前宣布子公司康希诺上海与德普世生物签署《mRNA个性化治疗型肿瘤疫苗共同开发战略合作框架协议》,受此消息刺激,公司股价8月26日大涨超16%。短期连续大涨后获利盘兑现压力显现。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"康希诺生物回调,mRNA肿瘤疫苗热度降温","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662729977","title":"【券商聚焦】国投证券:创新药有望开启新一轮高景气周期","url":"https://stock-news.laohu8.com/highlight/detail?id=2662729977","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662729977?lang=zh_cn&edition=full","pubTime":"2026-08-27 09:29","pubTimestamp":1787794154,"startTime":"0","endTime":"0","summary":"金吾财讯 | 国投证券研究指,医药景气新周期背景下,国内创新药产业链加速崛起。近年国家多举措全链条支持创新药发展,叠加国内得天独厚的人才储备和研发效率等多维优势,国内创新药持续加速崛起且逐步具备全球竞争力。与此同时,海外MNC陆续面临专利悬崖困境,对外采购和扩充创新管线需求与日俱增,国内创新药企顺势而为,以海外授权BD等形式实现创新出海,创新药有望开启新一轮高景气周期。风险提示:产品研发及审批速度低于预期;产品降价超预期风险;海外BD授权不及预期风险;计算及假设不及预期风险。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250109/YmQzNzBkZGZmOTg1MzM5MTQzMTA0Ng==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/YmQzNzBkZGZmOTg1MzM5MTQzMTA0Ng==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1989630","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0634319403.HKD","KCE","01177","LNGR","LU0314109678.HKD","LU0348783233.USD","LU1807302812.USD","LU0039217434.USD","LU1969619763.USD","LU1813983027.USD","LU0348825331.USD","02142","02616","LU0326950275.SGD","06978","KURE","LU0051755006.USD","LU1770034418.SGD","IE00BPRC5H50.USD","02269","IBBQ","LU0463099449.HKD","LU0880133367.SGD","IE0008369823.USD","MEDX","BK1589","LU0348767384.USD","LU0516422952.EUR","SG9999002562.SGD","LU0516423091.SGD","159992","LU0417516738.SGD","LU1226287875.USD","06160","LU0455707207.USD","161027","LU0140636845.USD","09926","01801","01877","LU0307460666.USD","LU2242644610.SGD","SG9999004220.SGD","LU0359201612.USD","01093","09995","06185","LU1794554557.SGD","09688"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164121698","title":"康希诺生物(06185)披露mRNA技术平台最新进展并签订肿瘤疫苗合作框架协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1164121698","media":"公告速递","labels":["corporation","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1164121698?lang=zh_cn&edition=full","pubTime":"2026-08-26 18:23","pubTimestamp":1787739799,"startTime":"0","endTime":"0","summary":"8月26日,康希诺生物股份公司发布自愿公告,披露其mRNA技术平台的研发进展,并宣布旗下全资子公司康希诺(上海)生物研发有限公司已与德普世(杭州)生物科技有限责任公司签订《mRNA个性化治疗型肿瘤疫苗共同开发战略合作框架协议》。\\n\\n公告显示,mRNA平台是公司重点布局的技术方向之一。康希诺生物正在同步推进mRNA预防用疫苗、治疗性生物制品及相关递送系统的开发。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662987537","title":"A股收评:沪指涨0.59%,超2900股上涨!大金融、有色金属板块领涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2662987537","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662987537?lang=zh_cn&edition=full","pubTime":"2026-08-26 15:05","pubTimestamp":1787727939,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0224","BK0188","LU0501845795.SGD","LU1655091616.SGD","BK0052","LU0880133367.SGD","000712","603398","BK0239","BK0028","LU1993786604.SGD","BK0254","BK0187","600095","LU1807302812.USD","BK0054","BK0278","BK0201","06185","000001","BK0276","IE00B0JY6N72.USD","LU1781817850.SGD","LU0072913022.USD","BK0077","LU1226287529.USD","LU0067412154.USD","BK0012","BK0048","688185","512400","BK0183","LU1580142542.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662613447","title":"港股速报 | 港股继续高开 马云出手 阿里巴巴涨超2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662613447","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662613447?lang=zh_cn&edition=full","pubTime":"2026-08-26 10:13","pubTimestamp":1787710394,"startTime":"0","endTime":"0","summary":"8月26日,港股市场早盘继续强势高开。早间开盘,恒生指数报25635.24点,高开124.14点,涨幅0.49%。恒生科技指数开盘报4622.98点,高开34.44点,涨幅0.75%。市场焦点方面,周一大跌之后,阿里巴巴-W(HK09988)连续反弹,今日早盘涨超2%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://stock.eastmoney.com/a/202608263854292594.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.eastmoney.com/a/202608263854292594.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0049853897.USD","LU0348814723.USD","LU0675040207.SGD","BK1501","LU1794554557.SGD","LU0819121731.USD","LU0173614495.USD","LU0823397285.USD","LU1188198961.HKD","LU0143863784.USD","HK0000107257.USD","LU0314109678.HKD","BABA","LU0516422952.EUR","LU0254981946.USD","BK0028","LU1720051017.SGD","HK0000320264.USD","LU0229945570.USD","LU0828237510.HKD","LU0348784397.USD","LU0096374516.USD","LU1044876610.USD","LU0577902538.SGD","LU0348788117.USD","LU2039709279.SGD","LU0488056044.USD","LU0708995583.HKD","LU0052750758.USD","LU0164872284.USD","LU0329678337.USD","LU0651947912.USD","LU1770036033.HKD","SG9999000459.SGD","BK1161","LU1568876251.USD","IE00B0JY6N72.USD","LU0611395673.USD","LU1115378108.SGD","LU1880398471.USD","LU0328353924.USD","LU0130518102.USD","LU0630378429.USD","LU0169518387.USD","LU0823038988.USD","LU1548497426.USD","HK0000151867.HKD","BK0147","LU0577902454.USD","BK1521","LU0348783662.USD","LU0819123356.HKD","LU0165289439.USD","LU1439103000.SGD","BK1517","LU1688375341.USD","LU0784639295.USD","LU1515016050.SGD","SG9999002463.SGD","SG9999004220.SGD","LU0456827905.SGD","BK1618","LU0862451837.USD","HK0000306685.HKD","LU0214875030.USD","IE0008368304.USD","SG9999001093.SGD","LU1023057109.AUD","IE0032431581.USD","09988","LU0320764599.SGD","LU0607220059.USD","LU1224709979.USD","LU1251922891.USD","LU0396098781.USD","LU2476274308.USD","LU1504937902.USD","IE00BMPRXN33.USD","LU0648000940.SGD","LU0061477393.USD","LU1048596156.SGD","LU0327786744.USD","IE0003895053.USD","LU0210526637.USD","LU0831093199.SGD","LU1868838027.USD","LU0287142896.SGD","BK1591","688185","LU0608807946.USD","LU0348783233.USD","LU0164865239.USD","LU0228659784.USD","LU1831875114.USD","LU2778985437.USD","SG9999006597.SGD","LU3063872942.SGD","LU2488822045.USD","LU0251144936.SGD","IE00B3M56506.USD","LU1282649810.SGD","LU0051755006.USD","LU0572944931.SGD","LU0823397103.USD","LU0589944569.HKD","BK1502","LU0048597586.USD","LU1769817096.USD","LU1051769294.HKD","LU1719994722.HKD","LU2152927971.USD","LU0261950983.USD","SG9999001226.SGD","LU0463099449.HKD","LU0540923850.HKD","LU1044875133.USD","LU0634319403.HKD","LU0054237671.USD","LU0823413660.USD","LU0072462343.USD","LU1813983027.USD","LU0228367735.SGD","LU0106252389.USD","HK0000320223.HKD","LU0918141887.USD","LU0149534421.HKD","LU0605514214.HKD","BK1586","LU0084288322.USD","HK0000286598.CNH","LU0163747925.USD","LU1328615791.USD","LU0640798160.USD","LU2242644610.SGD","LU0315179316.USD","LU0572939691.SGD","LU1810669033.SGD","LU1880383440.USD","LU1770034418.SGD","IE00BZ08YT58.USD","LU0197773160.USD","LU0577902371.SGD","LU0210527791.USD","BK1615","IE00BZ08YS42.EUR","SGXZ86797644.SGD","LU1960683339.HKD","LU0862451753.SGD","LU0345776255.USD","LU0244354667.USD","LU0469268626.HKD","LU0106959298.USD","LU0791590937.USD","LU2125910500.SGD","LU0823426480.USD","LU0831103253.SGD","LU0370786039.SGD","SG9999006514.SGD","LU0441854154.USD","LU1366334578.USD","BK1574","BK1249","SGXZ90724238.SGD","LU0235996351.USD","BK1584","LU0651946864.USD","LU0293314216.USD","LU0329678170.USD","LU1993786604.SGD","LU0572940350.SGD","LU0588545730.USD","LU1211504680.USD","LU0541501648.USD","LU0320764243.SGD","LU2226246903.HKD","LU0431992006.USD","BK0150","LU0048388663.USD","LU0823426308.USD","BK0080","LU0127658192.USD","LU2476274720.SGD","BK1191","LU0856984785.SGD","LU0417516571.SGD","HK0000306701.USD","LU0106259558.USD","LU1242518857.USD","LU0502904849.HKD","SG9999001689.USD","LU2097828714.EUR","ALBmain","LU0886674414.USD","LU1282648689.USD","LU0384037296.USD","LU1316542783.SGD","LU0577902611.USD","LU1366334651.USD","LU0823041008.USD","LU0011963245.USD","LDEM","LU0561508036.HKD","LU0630378692.HKD","IE00BMPRXR70.SGD","IE0034224299.USD","IE00B543WZ88.USD","LU0048580855.USD","LU0543330566.HKD","LU0231483743.USD","LU0348735423.USD","89988","HBBD.SI","LU1303224171.USD","LU0531971595.HKD","LU1961090484.USD","IE00B0169N27.USD","LU0823039010.USD","LU0359201612.USD","LU1981816686.USD","LU0499858602.USD","IE00BZ08YR35.GBP","LU0348825331.USD","LU0762541174.USD","SGXZ62798434.SGD","000598","LU0047713382.USD","LU0456846285.SGD","FDNI","LU0029875118.USD","LU0128522157.USD","LU1807302812.USD","LU0499858438.USD","LU2097828474.EUR","LU0449509016.USD","LU0417516902.SGD","LU0737861699.HKD","LU0871576103.HKD","LU0516423174.USD","LU0196878994.USD","LU0181495838.USD","IE00B5MMRT66.SGD","LU0821914370.USD","LU2294711473.HKD","LU0898667661.SGD","LU0054450605.USD","LU0315178854.USD","LU0149721374.USD","LU0348816934.USD","LU0594300419.USD","LU1201861165.SGD","LU0588546209.SGD","LU0700851271.USD","LU0029874905.USD","LU1481107354.HKD","LU0823040885.USD","SG9999001903.USD","LU0117841782.USD","LU1880398554.USD","LU1720050803.USD","BK1588","LU0868486357.SGD","LU1282649067.USD","LU2097828805.USD","LU2449936058.SGD","SG9999002562.SGD","LU0531970944.HKD","LU0130103400.USD","BK1608","BK0101","LU0455707207.USD","LU0449515922.USD","LU0348805143.USD","LU0828237940.HKD","LU2293587155.HKD","LU1048484197.HKD","IE00BPRC5H50.USD","LU0823413587.USD","LU0417516738.SGD","LU1196710864.SGD","LU1105468828.SGD","LU0043850808.USD","LU0608807433.USD","BK1610","LU0359202008.SGD","LU0197773673.USD","LU2045819591.USD","BK1142","BK1575","06185","LU0143863198.USD","LU1769817179.HKD","LU0128522744.USD","LU1868837565.USD","LU2087589342.USD","LU0762542818.HKD","LU1956131251.USD","LU2125910849.SGD","BK1515","BK0135","LU0543330483.HKD","LU0588545490.SGD","LU2097829019.USD","LU0264606111.USD","LU0648948544.HKD","SG9999014674.SGD","LU0307460666.USD","BKF","LU0140636845.USD","LU0477156797.USD","LU0516422440.USD","SG9999001051.SGD","LU0791591158.USD","LU2097828631.EUR","LU0516423091.SGD","LU1282649141.HKD","LU0865486749.SGD","LU0797268264.HKD","LU0890818403.SGD","LU2257852520.SGD","BK0243","SG9999000327.SGD","LU1044874839.SGD","LU1323998911.USD","LU1048588211.SGD","LU0577902298.EUR","LU1051768304.USD","LU0593848301.USD","LU0261947096.USD","LU0541502299.USD","LU0642271901.SGD","LU0039217434.USD","LU0359201885.HKD","LU0737861772.HKD","LU0164880469.USD","LU0211977185.USD","LU1655091459.SGD","LU2357305700.SGD","LU1282651121.HKD","LU0594300179.USD","KWEB","LU0588545904.SGD","LU1242518931.SGD","LU0762540952.USD","LU1224444064.USD","LU0117844026.USD","LU0650527681.SGD","LU1808992512.USD","SG9999002828.SGD","LU1282651048.USD","LU0345775950.USD","LU1568876335.HKD","LU0918141705.HKD","LU0259732245.USD","LU0326950275.SGD","LU0708995153.HKD","LU0348827113.USD","LU1880383366.USD","LU0979878070.USD","LU2399975544.HKD","LU1642822792.SGD","LU0672654166.SGD","LU1328277881.USD","LU0320764755.SGD","BK0188","LU0873338254.USD","LU0132412106.USD","LU0516422366.SGD","LU2097828557.USD","LU1720051108.HKD","CXSE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662476606","title":"港股生物医药股大涨,康希诺生物涨逾18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662476606","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662476606?lang=zh_cn&edition=full","pubTime":"2026-08-26 09:37","pubTimestamp":1787708220,"startTime":"0","endTime":"0","summary":"模拟交易客户端港股生物医药股延续近期强势,康希诺生物大涨18%,信达生物绩后涨超11%,云顶新耀涨超8%,康方生物涨超6%,荣昌生物涨超5%。个股消息面上,康希诺生物宣布,子公司康希诺上海与德普世生物正式签署《mRNA个性化治疗型肿瘤疫苗共同开发战略合作框架协议》。本次合作面向全球,聚焦消化道实体瘤及罕见肿瘤治疗领域,覆盖早期研发、临床转化、注册申报及商业化等环节。目前,公司商业化产品矩阵已扩充至20款。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/2026-08-26/doc-iniprcpw5390717.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1515","BK4588","BK1191","BK1574","161726","KCAI","VXUS","BK1161","399441","BK4581","XBI","BK4585","06185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662546766","title":"港股异动 | 康希诺生物大升16%,与德普世生物达成mRNA个性化治疗型肿瘤疫苗战略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2662546766","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662546766?lang=zh_cn&edition=full","pubTime":"2026-08-26 09:32","pubTimestamp":1787707951,"startTime":"0","endTime":"0","summary":"消息面上,$康希诺$生物宣布,子公司康希诺上海与德普世$生物$正式签署《mRNA个性化治疗型肿瘤疫苗共同开发战略合作框架协议》。双方将发挥各自在mRNA疫苗技术及肿瘤新抗原发现与设计领域的优势,共同推进mRNA个性化治疗型肿瘤疫苗的研发与商业化。里昂发布研报称,由于Moderna正于肺癌、肾癌及膀胱癌进行相同平台的临床研究,此次成功属平台级别的估值重估。该行指出,康希诺生物的开发路线及抗原设计与Moderna大致相若。","market":"hk","thumbnail":"https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1485732.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"康希诺生物与德普世生物达成mRNA个性化治疗型肿瘤疫苗战略合作","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","06185","BK1574","BK1161","BK4585","688185","BK4588","KCAI","159646","VXUS","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138522044","title":"异动解读|康希诺生物盘中上涨14.34%,与德普世生物达成mRNA肿瘤疫苗战略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=1138522044","media":"行情直击","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1138522044?lang=zh_cn&edition=full","pubTime":"2026-08-26 09:31","pubTimestamp":1787707863,"startTime":"0","endTime":"0","summary":"8月26日,康希诺生物盘中上涨14.34%,报32.48港元,成交额2057.59万港元。消息面上,8月25日公司宣布子公司康希诺上海与德普世生物正式签署《mRNA个性化治疗型肿瘤疫苗共同开发战略合作框架协议》,双方将共同推进mRNA个性化治疗型肿瘤疫苗的研发与商业化,合作面向全球,聚焦消化道实体瘤及罕见肿瘤治疗领域。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康希诺生物大涨,携手德普世开发mRNA肿瘤疫苗","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662780362","title":"康希诺生物与德普世生物达成mRNA治疗型肿瘤疫苗战略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2662780362","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662780362?lang=zh_cn&edition=full","pubTime":"2026-08-25 17:15","pubTimestamp":1787649338,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["06185","BK1515","BK1161","BK1574","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142058341","title":"康希诺生物(06185)将于9月3日举行线上半年报业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=1142058341","media":"公告速递","labels":["conferences","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1142058341?lang=zh_cn&edition=full","pubTime":"2026-08-25 17:03","pubTimestamp":1787648610,"startTime":"0","endTime":"0","summary":"康希诺生物股份公司8月26日公告,公司将参加“2026年天津辖区上市公司投资者网上集体接待日暨半年报业绩说明会”。公司方面,董事长兼总经理宇学峰、董事会秘书崔进、代财务负责人刘明将出席会议。届时,公司将围绕2026年半年度业绩、公司治理、发展战略及经营状况等投资者关注的问题进行交流。投资者如有疑问,可通过以下方式联系公司:电话022-58213766,邮箱ir@cansinotech.com。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662878247","title":"智通AH统计|8月25日","url":"https://stock-news.laohu8.com/highlight/detail?id=2662878247","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662878247?lang=zh_cn&edition=full","pubTime":"2026-08-25 16:37","pubTimestamp":1787647022,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,截止8月25日收盘,东北电气、浙江世宝、弘业期货分列AH溢价率前三位,溢价率分别为1068.83%、374.66%、324.43%;宁德时代、药明康德、招商银行分列AH溢价率末三位,溢价率分别为-25.61%、-5.56%、-4.19%。其中东北电气、君正股份、康希诺生物的偏离值位居前三,分别为70.19%、56.97%、37.16%;另外,南华期货股份、长飞光纤光缆、广合科技的偏离值位居后三,分别为-57.90%、-38.35%、-25.98%。 前十大AH股溢价率排行。 股票名称H股(港元)A股溢价率↓偏离值","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260825/32346290.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["00042","00956","02338","00300","01989","02691","06826","01349","03223","03678","03130","02359","03750","07233","83130","02827","03328","00981","399300","03308","03759","01513","03143","EWH","02218","01057","02846","06185","03968","02475","82846","03296","06869","01812","06613","00317","00187","LU1504937902.USD","01033","00568","LU0516423174.USD","00553","159982","03986","83188","02768","02899","01108","03188"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1104306479","title":"异动解读|康希诺生物盘中下跌5.16%,mRNA癌症疫苗消息刺激暴涨后持续回调","url":"https://stock-news.laohu8.com/highlight/detail?id=1104306479","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1104306479?lang=zh_cn&edition=full","pubTime":"2026-08-24 13:03","pubTimestamp":1787547836,"startTime":"0","endTime":"0","summary":"8月24日,康希诺生物盘中下跌5.16%,报27.96港元,成交额2.05亿港元。消息面上,此前Moderna与默沙东联合研发的个性化mRNA癌症疫苗三期临床试验取得积极结果,系全球首个mRNA肿瘤疫苗三期临床成功案例,康希诺生物因拥有mRNA技术平台布局及与Moderna大致相若的开发路线,8月20日单日暴涨约48.59%。此后公司发布异动公告称A股三日累涨超30%,并表示不存在应披露而未披露的重大信息,mRNA平台仅为公司布局的技术平台之一。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"康希诺生物回调,mRNA疫苗热度退潮","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661244437","title":"【券商聚焦】交银国际:中国内地mRNA疫苗产业整体低估严重","url":"https://stock-news.laohu8.com/highlight/detail?id=2661244437","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661244437?lang=zh_cn&edition=full","pubTime":"2026-08-24 09:18","pubTimestamp":1787534313,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际表示,Moderna与默沙东共同宣布,intismeran联合K药辅助治疗IIB-IV期黑色素瘤的III期INTerpath-001研究达主要终点 。该机构认为,中国内地mRNA疫苗企业正处于全球公共卫生事件后的低谷期,产业整体低估严重,但海外可比产品的研发成功和适应症领域的拓展有望推动投资情绪和估值修复。此外,康希诺、智飞生物/沃森生物/康华生物等布局mRNA技术、处于估值底部的疫苗企业也值得持续关注。","market":"other","thumbnail":"https://static.szfiu.com/news/20250109/M2QyMTYxN2UxNmI4NDk2OTg5NThlNDVhNTUzNjZhZTcxMjcxMzE0NDc4MDA=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/M2QyMTYxN2UxNmI4NDk2OTg5NThlNDVhNTUzNjZhZTcxMjcxMzE0NDc4MDA=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1989096","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995","LU1960683339.HKD","LU0417516571.SGD","LU0244354667.USD","MRNY","BK1191","LU1794554557.SGD","BK1147","LU0181495838.USD","LU1688375341.USD","LU1242518931.SGD","LU2488822045.USD","LU0880133367.SGD","LU1303224171.USD","LU1226287792.SGD","01877","BK1588","LU2097828557.USD","LU0307460666.USD","06160","09688","LU0228659784.USD","01177","KURE","06185","LU0043850808.USD","LU0516422366.SGD","BK1576","01093","02142","LU0359201612.USD","LU0320764599.SGD","09926","LU0979878070.USD","MRNX","LU0348767384.USD","KCE","LU0067412154.USD","02269","01801","BK1589","LU0828237510.HKD","LU0516423174.USD","LU0348766576.USD","LU0561508036.HKD","LU0588546209.SGD","SG9999002562.SGD","LU1008478684.HKD","02616","03329"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cansinotech.com","stockEarnings":[{"period":"1week","weight":0.0926},{"period":"1month","weight":0.2672},{"period":"3month","weight":0.1596},{"period":"6month","weight":-0.0682},{"period":"1year","weight":-0.3962},{"period":"ytd","weight":-0.1552}],"compareEarnings":[{"period":"1week","weight":0.0019},{"period":"1month","weight":-0.0123},{"period":"3month","weight":-0.0181},{"period":"6month","weight":0.0126},{"period":"1year","weight":0.0195},{"period":"ytd","weight":-0.0025}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"康希诺生物股份公司是一家处于临床阶段的中国疫苗公司。该公司的产品包括埃博拉病毒疫苗Ad5-EBOV、脑膜炎球菌疫苗MCV2和MCV4、肺炎球菌疫苗PBPV和重组新型冠状病毒疫苗等。其产品主要应用于脑膜炎、百白破和肺炎领域。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.030578},{"month":2,"riseRate":0.857143,"avgChangeRate":0.172684},{"month":3,"riseRate":0.142857,"avgChangeRate":-0.060436},{"month":4,"riseRate":0.625,"avgChangeRate":0.049828},{"month":5,"riseRate":0.25,"avgChangeRate":-0.051769},{"month":6,"riseRate":0.5,"avgChangeRate":0.015607},{"month":7,"riseRate":0.625,"avgChangeRate":0.054796},{"month":8,"riseRate":0.25,"avgChangeRate":-0.091996},{"month":9,"riseRate":0.714286,"avgChangeRate":0.068326},{"month":10,"riseRate":0.428571,"avgChangeRate":0.059174},{"month":11,"riseRate":0.571429,"avgChangeRate":0.088604},{"month":12,"riseRate":0.571429,"avgChangeRate":-0.035813}],"exchange":"SEHK","name":"康希诺生物","nameEN":"CANSINOBIO"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康希诺生物(06185)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康希诺生物(06185)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康希诺生物,06185,康希诺生物股票,康希诺生物股票老虎,康希诺生物股票老虎国际,康希诺生物行情,康希诺生物股票行情,康希诺生物股价,康希诺生物股市,康希诺生物股票价格,康希诺生物股票交易,康希诺生物股票购买,康希诺生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康希诺生物(06185)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康希诺生物(06185)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}